Market open
$
1.22
Change
-0.03 -2.40%
Volume
Volume 2.72m
Feb 7, 2023, 1:40 p.m.
Real time quotes
Previous close
$ 1.25
$ 1.22
Change
-0.03 -2.40%
Day low
Day high
$1.21
$1.26

52 week low
52 week high
$1.09
$4.53

Market cap
$273.61M
Average volume
5.29M
P/E ratio
N/A
Rev. per Employee
N/A
EPS
-0.35
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on OCGN
-
Ocugen Inc. stock falls Monday, underperforms market
- MarketWatch Automation
-
Ocugen Inc. stock falls Friday, underperforms market
- MarketWatch Automation
-
Ocugen Inc. stock rises Thursday, outperforms market
- MarketWatch Automation
-
Ocugen Inc. stock remains steady Wednesday, underperforms market
- MarketWatch Automation
-
Ocugen Inc. stock rises Tuesday, outperforms market
- MarketWatch Automation
-
Ocugen Inc. stock falls Monday, underperforms market
- MarketWatch Automation
-
Ocugen Inc. stock rises Friday, outperforms market
- MarketWatch Automation
-
Ocugen Inc. stock falls Thursday, underperforms market
- MarketWatch Automation
-
Ocugen Inc. stock remains steady Wednesday, still outperforms market
- MarketWatch Automation
-
Ocugen Inc. stock rises Tuesday, outperforms market
- MarketWatch Automation
-
Ocugen Inc. stock rises Monday, outperforms market
- MarketWatch Automation
-
Ocugen Inc. stock falls Thursday, underperforms market
- MarketWatch Automation
-
Ocugen Inc. stock falls Wednesday, underperforms market
- MarketWatch Automation
-
Ocugen Inc. stock falls Tuesday, underperforms market
- MarketWatch Automation
-
Ocugen Inc. stock falls Friday, underperforms market
- MarketWatch Automation
-
Ocugen Inc. stock rises Thursday, outperforms market
- MarketWatch Automation
-
Ocugen Inc. stock falls Wednesday, underperforms market
- MarketWatch Automation
-
Ocugen Inc. stock rises Tuesday, outperforms market
- MarketWatch Automation
-
Ocugen Inc. stock falls Monday, underperforms market
- MarketWatch Automation
- Loading more headlines...
Analyst Ratings
-
BTIG Upgrades Histogenics To Buy, Sets $3.50 Price Target
- Benzinga.com
-
BTIG Research Initiates Histogenics With Buy
- Benzinga.com
Other News on OCGN
-
Abingworth LLP Buys 2, Sells 3 in 3rd Quarter
- GuruFocus.com
-
Ocugen rises 9% after Q3 loss in-line with estimates
- Seeking Alpha
-
Ocugen, Inc. (OCGN) Q3 2022 Earnings Call Transcript
- Seeking Alpha
-
- Edgar Online - (EDG = 10Q, 10K)
-
Ocugen GAAP EPS of -$0.10 in-line
- Seeking Alpha
-
Moderna, Novavax hit 52-week lows
- Seeking Alpha
-
4 stocks to watch on Wednesday: Apple, UiPath and more
- Seeking Alpha
-
Ocugen gains on licensing deal for intranasal COVID-19 vaccine
- Seeking Alpha
-
Ocugen announces peer-reviewed publication on COVID-19 vaccine
- Seeking Alpha
-
Why Ocugen Stock Topped the Market Today
- Motley Fool
-
Why Ocugen Stock Is Racing Higher Today
- Motley Fool
-
How Investors Can Outperform Warren Buffett
- Motley Fool
-
Here's How This Beaten-Down Stock Could 10X by 2024
- Motley Fool
-
1 Robinhood Stock to Avoid Right Now
- Motley Fool
-
Ocugen, Inc. (OCGN) Q2 2022 Earnings Call Transcript
- Motley Fool
-
- Edgar Online - (EDG = 10Q, 10K)
-
Ocugen GAAP EPS of -$0.09 misses by $0.01
- Seeking Alpha
- Loading more headlines...
Press Releases on OCGN
-
Ocugen, Inc. to Ring the Nasdaq Stock Market Closing Bell
- GlobeNewswire
-
Ocugen to Present at 3rd Annual Dry AMD Therapeutics Summit
- GlobeNewswire
-
4 Stocks to Watch on Wednesday Are AAPL, OCGN SMTS, and PATH
- PressReach.com
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com